More cancer prevention and control efforts are needed.
Posted March 12th, 2022
Cancers are a major contributor to disease burden worldwide.
Both total cancer incidence and cancer death rates increased between 2010 and 2019, according to an analysis of the Global Burden of Diseases, Injuries, and Risk Factors Study published in JAMA Oncology.
Total Cancer Incidence Rate From 2010 to 2019 in Both Sexes
Total cancer excludes nonmelanoma skin cancers. Annualized rate of change from 2010 to 2019 represents the average percentage change per year during this period, with negative values indicating decreasing incidence rates and positive values indicating increasing incidence rates.
Total Cancer Mortality Rate From 2010 to 2019 in Both Sexes
Total cancer excludes nonmelanoma skin cancers. Annualized rate of change from 2010 to 2019 represents the mean percentage change per year during this period, with negative values indicating decreasing mortality rates and positive values indicating increasing mortality rates.
In this systematic analysis, there were 23.6 million new global cancer cases in 2019 (17.2 million when excluding those with nonmelanoma skin cancer), 10.0 million cancer deaths, and an estimated 250 million disability-adjusted life years estimated to be due to cancer; since 2010, these represent increases of 26.3%, 20.9%, and 16.0%, respectively. Absolute cancer burden increased in all Sociodemographic Index (SDI) quintiles since 2010, but the largest percentage increases occurred in the low and low-middle SDI quintiles.
The results of this systematic analysis suggest that the global burden of cancer is substantial and growing, with burden differing by SDI. These results provide comprehensive and comparable estimates that can potentially inform efforts toward equitable cancer control around the world.
Abstracted from the study "Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019" by TACT Genomics.